首页> 美国卫生研究院文献>Springer Open Choice >In vitro metabolism of synthetic cannabinoid AM1220 by human liver microsomes and Cunninghamella elegans using liquid chromatography coupled with high resolution mass spectrometry
【2h】

In vitro metabolism of synthetic cannabinoid AM1220 by human liver microsomes and Cunninghamella elegans using liquid chromatography coupled with high resolution mass spectrometry

机译:液相色谱-高分辨质谱联用技术在人肝微粒体和秀丽线虫体外合成大麻素AM1220代谢中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeIdentifying intake of synthetic cannabinoids generally requires the metabolism data of the drugs so that appropriate metabolite markers can be targeted in urine testing. However, the continuous appearance of new cannabinoids during the last decade has made it difficult to keep up with all the compounds including {1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone (AM1220). In this study, metabolism of AM1220 was investigated with human liver microsomes and the fungus Cunninghamella elegans.
机译:目的确定合成大麻素的摄入量通常需要药物的代谢数据,以便可以在尿液测试中确定合适的代谢物标记物。然而,在过去的十年中,不断出现的新大麻素使其难以跟上所有化合物,包括{1-[(1-甲基哌啶丁-2-基)甲基] -1H-吲哚-3-基}(萘) -1-基)甲酮(AM1220)。在这项研究中,研究了人肝微粒体和秀丽线虫Cunninghamella elegans对AM1220的代谢作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号